Iron Dextran Injection

[09 May 2016]

Products Affected - Description

All presentations are currently available

Reason for the Shortage

  • Actavis had INFeD on shortage due to manufacturing delays.
  • American Regent's Dexferrum injection has been unavailable since 2013.
  • Other parenteral iron products are not affected by this shortage.

Available Products

INFeD injection, Actavis
50 mg/mL, 2 mL vial, 10 count (NDC 52544-0931-02)

Estimated Resupply Dates

Actavis has INFeD injection available.

Related Shortages


May 9, April 8, March 21, February 29, 4 and 1, January 27 and 13, 2016, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
ASHP Product Listing